Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Hodgkins Lymphoma (NHL) Patients, With CD19+B Cell Lymphomas”

Showing 6 of 0 results

Early research (Phase 1)Looking for participantsNCT06037018
What this trial is testing

Safety Study of CC312 in Adult Patients With Relapsed/Refractory CD19 Positive B-cell Hematologic Malignancies

Who this might be right for
Non-hodgkin LymphomaAcute Lymphoblastic LeukaemiaChronic Lymphocytic Leukemia
CytoCares Inc 44
Testing effectiveness (Phase 2)Study completedNCT01685008
What this trial is testing

Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Non-Hodgkin Lymphoma
MorphoSys AG 92
Early research (Phase 1)WithdrawnNCT02274506
What this trial is testing

Infusion of Allogeneic, 3rd Party CD19-specific T Cells

Who this might be right for
Blood And Marrow TransplantationLeukemiaLymphoma
M.D. Anderson Cancer Center
Early research (Phase 1)WithdrawnNCT03768310
What this trial is testing

CD19.CAR-multiVSTs for Patients With CD19+ B-ALL or NHL Undergoing Related Allogeneic HSCT (CARMA)

Who this might be right for
Non-hodgkin LymphomaAcute Lymphoblastic Leukemia
Baylor College of Medicine
Testing effectiveness (Phase 2)Looking for participantsNCT06698484
What this trial is testing

To Evaluate Safety and Efficacy of Autologous CD19 Chimeric Antigen Receptor (CAR)-T Cells in Relapsed/Refractory B- Non-Hodgkin Lymphoma (B-NHL)

Who this might be right for
Relapsed/Refractory B- Cell Non-Hodgkin Lymphoma
National University of Malaysia 20
Early research (Phase 1)WithdrawnNCT07049432
What this trial is testing

N-803 Maintenance Therapy Post CAR T-cell Therapy in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas

Who this might be right for
B-cell Non Hodgkin Lymphoma
University of Utah

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation